ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Research vs. Delivery? Advisors Debate NCI Role In Review of Community Program.

November 21, 2008

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

February 6, 1987

Survivorship Studies Unfocused As Total Research Increases

November 25, 2011

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995

Appropriators Project 1.2% Increase for NIH, Due to Budget Plan

June 20, 1997

First TIL Results: Four Patients, All Responded, One Complete; Panel Pens Reauthorization Drive

November 27, 1987